ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106442 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106442; 2) Community: the network communities that were significantly associated with the response to NSC 106442; 3) Molecule: the relationships between components within communities and NSC 106442; 4) MDR: the compounds that were significantly associated with the NSC 106442.

NSC Compound Enrichment Correlation
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.00592008956008459 0.44675448
NSC 752703 Null 0.00592008956008459 0.22167934
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.00592008956008459 0.10117005
NSC 98572 .beta.-Resorcylaldehyde, 2-pyridylhydrazone 0.00592008956008459 0.25529453
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.00626555836518783 0.4335369
NSC 621727 Null 0.00626555836518783 0.059569687
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.00626555836518783 0.57894276
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.00626555836518783 0.44597933
NSC 664271 Null 0.00626555836518783 0.53573479
NSC 671190 Null 0.00626555836518783 0.48441254
Total:108  Current:19    [First] [Prev] [Next] [Last]